Compare Procter & Gamble Health with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs PIRAMAL ENTERPRISES - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH PIRAMAL ENTERPRISES PROCTER & GAMBLE HEALTH/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 52.9 15.2 348.3% View Chart
P/BV x 4.8 1.0 496.2% View Chart
Dividend Yield % 9.9 1.8 539.1%  

Financials

 PROCTER & GAMBLE HEALTH   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
PIRAMAL ENTERPRISES
Mar-19
PROCTER & GAMBLE HEALTH/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3,5493,303 107.5%   
Low Rs1,3011,797 72.4%   
Sales per share (Unadj.) Rs511.4716.5 71.4%  
Earnings per share (Unadj.) Rs61.379.7 76.9%  
Cash flow per share (Unadj.) Rs74.0107.9 68.6%  
Dividends per share (Unadj.) Rs440.0028.00 1,571.4%  
Dividend yield (eoy) %18.11.1 1,652.1%  
Book value per share (Unadj.) Rs927.81,477.5 62.8%  
Shares outstanding (eoy) m16.60184.45 9.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.73.6 133.2%   
Avg P/E ratio x39.632.0 123.7%  
P/CF ratio (eoy) x32.823.6 138.7%  
Price / Book Value ratio x2.61.7 151.5%  
Dividend payout %717.935.1 2,043.5%   
Avg Mkt Cap Rs m40,257470,292 8.6%   
No. of employees `0001.17.8 14.5%   
Total wages/salary Rs m1,31322,504 5.8%   
Avg. sales/employee Rs Th7,486.716,899.4 44.3%   
Avg. wages/employee Rs Th1,157.62,877.7 40.2%   
Avg. net profit/employee Rs Th897.21,879.9 47.7%   
INCOME DATA
Net Sales Rs m8,490132,153 6.4%  
Other income Rs m2443,128 7.8%   
Total revenues Rs m8,734135,281 6.5%   
Gross profit Rs m1,48266,290 2.2%  
Depreciation Rs m2115,202 4.1%   
Interest Rs m044,097 0.0%   
Profit before tax Rs m1,51420,119 7.5%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m5638,611 6.5%   
Profit after tax Rs m1,01714,701 6.9%  
Gross profit margin %17.550.2 34.8%  
Effective tax rate %37.142.8 86.8%   
Net profit margin %12.011.1 107.7%  
BALANCE SHEET DATA
Current assets Rs m15,343122,742 12.5%   
Current liabilities Rs m1,960310,810 0.6%   
Net working cap to sales %157.6-142.3 -110.8%  
Current ratio x7.80.4 1,982.0%  
Inventory Days Days4923 211.3%  
Debtors Days Days2839 73.2%  
Net fixed assets Rs m1,209116,904 1.0%   
Share capital Rs m166369 45.0%   
"Free" reserves Rs m15,235272,161 5.6%   
Net worth Rs m15,401272,530 5.7%   
Long term debt Rs m0270,196 0.0%   
Total assets Rs m17,595856,261 2.1%  
Interest coverage xNM1.5-  
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.50.2 312.6%   
Return on assets %5.86.9 84.2%  
Return on equity %6.65.4 122.5%  
Return on capital %10.312.4 82.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,63615,200 10.8%   
Fx outflow Rs m4,3684,889 89.3%   
Net fx Rs m-2,73210,312 -26.5%   
CASH FLOW
From Operations Rs m-1,304-115,975 1.1%  
From Investments Rs m12,697-8,265 -153.6%  
From Financial Activity Rs m-301107,525 -0.3%  
Net Cashflow Rs m11,093-16,650 -66.6%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 4.0 455.0%  
FIIs % 1.0 26.6 3.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 16.5 176.4%  
Shareholders   28,591 93,274 30.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES  WOCKHARDT  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Telecom and Automobiles Stocks Lose(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.1% while the Hang Seng is down 0.1%.

Related Views on News

PIRAMAL ENTERPRISES Surges by 5%; BSE HEALTHCARE Index Up 1.0% (Market Updates)

Oct 18, 2019 | Updated on Oct 18, 2019

PIRAMAL ENTERPRISES share price has surged by 5% and its current market price is Rs 1,546. The BSE HEALTHCARE is up by 1.0%. The top gainers in the BSE HEALTHCARE Index is PIRAMAL ENTERPRISES (up 5.1%). The top losers are PROCTER & GAMBLE HEALTH and DR. REDDYS LAB .

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Oct 18, 2019 12:15 PM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS